Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant

Paul Elliott*, David Haw, Haowei Wang, Oliver Eales, Caroline E. Walters, Kylie E. C. Ainslie, Christina Atchison, Claudio Fronterre, Peter J. Diggle, Andrew J Page, Alexander J. Trotter, Sophie J. Prosolek, The COVID-19 Genomics UK (COG-UK) Consortium, Deborah Ashby, Christl A. Donnelly, Wendy Barclay, Graham Taylor, Graham Cooke, Helen Ward, Ara DarziSteven Riley*, Samuel C Robson, Nicholas J. Loman, Thomas R. Connor, Tanya Golubchik, Rocio T Martinez Nunez, Catherine Ludden, Sally Corden, Ian Johnston, David Bonsall, Colin P. Smith, Giselda Bucca, M Estee Torok, Kordo Saeed, Jacqui A Prieto, David K Jackson, William L Hamilton, Luke B Snell, Catherine Moore, Ewan M. Harrison, Rachel J Williams, Hannah Jones, John A Hartley, Chris Williams, Darren L Smith, Matthew Bashton, Andrew Nelson, Gregory R Young, Clare M McCann, Wen C Yew

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)
24 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant'. Together they form a unique fingerprint.

Agricultural and Biological Sciences